MediPharm Labs (TSE:LABS) Reaches New 1-Year Low – What’s Next?

Shares of MediPharm Labs Corp. (TSE:LABS) hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as C$0.06 and last traded at C$0.07, with a volume of 214232 shares traded. The stock had previously closed at C$0.07.

MediPharm Labs Stock Performance

The company has a market cap of C$29.45 million, a P/E ratio of -2.33 and a beta of -0.38. The stock has a 50 day moving average price of C$0.07 and a two-hundred day moving average price of C$0.07. The company has a quick ratio of 3.10, a current ratio of 3.20 and a debt-to-equity ratio of 1.12.

About MediPharm Labs

Founded in 2015, MediPharm Labs specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API), and advanced derivative products produced in a GMP-certified facility with ISO-standard clean rooms. MediPharm has invested in an expert research-driven team, state-of-the-art technology, advanced purification methodologies, and purpose-built facilities to deliver pure, trusted, precision-dosed cannabinoid products for domestic and international markets.